ABIGAIL CHRISTINA LEONORAS: Open Payments
NPI 1326562166 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 31 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $502 · 2025 $696
Food & beverage: $597Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $208 |
| GlaxoSmithKline, LLC. | 12 | $174 |
| GENZYME CORPORATION | 8 | $159 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Optinose US, Inc. | 1 | $28 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Phadia US Inc. | 1 | $14 |
Products named: DUPIXENT, NUCALA, Xhance, ImmunoCAP.
Industry payments across NV — which companies pay providers there.
